{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:38:58Z","timestamp":1790213938173,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSCZY0134"],"award-info":[{"award-number":["2026NSFSCZY0134"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2025HXFH018"],"award-info":[{"award-number":["2025HXFH018"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3403200"],"award-info":[{"award-number":["2023YFC3403200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92574109"],"award-info":[{"award-number":["92574109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472774"],"award-info":[{"award-number":["82472774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T25B2029"],"award-info":[{"award-number":["T25B2029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:30:09Z","timestamp":1770395409000},"page":"3112-3131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["ALKBH5 orchestrates ferroptosis-driven tumor suppression: An LLM-powered discovery in prostate cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Xianyanling","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhou","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0617-9286","authenticated-orcid":false,"given":"Jianzhong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.003_bib1","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.02.003_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa2214676","article-title":"Rucaparib or Physician's Choice in Metastatic Prostate Cancer","volume":"388","author":"Fizazi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13059-016-0989-x","article-title":"MUFFINN: cancer gene discovery via network analysis of somatic mutation data","volume":"17","author":"Cho","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cels.2017.09.003","article-title":"Network-Based Coverage of Mutational Profiles Reveals Cancer Genes","volume":"5","author":"Hristov","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.ymthe.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fgene.2019.00013","article-title":"deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fmolb.2019.00044","article-title":"Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations","volume":"6","author":"Agajanian","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trecan.2024.12.001","article-title":"Artificial intelligence-based biomarkers for treatment decisions in oncology","volume":"11","author":"Ligero","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-025-57430-4","article-title":"DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241554","article-title":"Accuracy of Large Language Model-based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI Reports","volume":"315","author":"Bhayana","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.ymthe.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.5534\/wjmh.240173","article-title":"The In-depth Comparative Analysis of Four Large Language AI Models for Risk Assessment and Information Retrieval from Multi-Modality Prostate Cancer Work-up Reports","volume":"43","author":"Yuan","year":"2025","journal-title":"World J. Mens Health"},{"key":"10.1016\/j.ymthe.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijrobp.2024.07.2149","article-title":"Autodelineation of Treatment Target Volume for Radiation Therapy Using Large Language Model-Aided Multimodal Learning","volume":"121","author":"Rajendran","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ymthe.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13321-025-00962-0","article-title":"Improving drug repositioning with negative data labeling using large language models","volume":"17","author":"Picard","year":"2025","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ymthe.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12935-020-01450-1","article-title":"The biological function of m6A demethylase ALKBH5 and its role in human disease","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.7150\/thno.61178","article-title":"Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s11658-024-00628-z","article-title":"METTL3-mediated m(6)A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy","volume":"29","author":"Cheng","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ymthe.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-024-01994-0","article-title":"Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1080\/21655979.2021.2001936","article-title":"Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R)","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.ymthe.2026.02.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119180","article-title":"The FTO m(6)A demethylase inhibits the invasion and migration of prostate cancer cells by regulating total m(6)A levels","volume":"271","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41420-022-01003-7","article-title":"N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12967-025-06938-w","article-title":"Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy","volume":"23","author":"An","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13105-019-00690-8","article-title":"ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1","volume":"75","author":"Zhang","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2026.02.003_bib27","first-page":"E2047","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/atm-20-3079","article-title":"ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m(6)A-dependent manner","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-022-01647-0","article-title":"The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41556-025-01667-0","article-title":"Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA","volume":"27","author":"Chen","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-020-01161-1","article-title":"m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107\/LATS2-mediated YAP activity in NSCLC","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","article-title":"ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2\u03b1-Mediated Glycolysis","volume":"23","author":"Yu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","article-title":"ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ajhg.2024.08.010","article-title":"Assessing the utility of large language models for phenotype-driven gene prioritization in the diagnosis of rare genetic disease","volume":"111","author":"Kim","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-022-00446-5","article-title":"Cancer proteogenomics: current impact and future prospects","volume":"22","author":"Mani","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: from laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.02.003_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02671-8","article-title":"A computational approach for the discovery of significant cancer genes by weighted mutation and asymmetric spreading strength in networks","volume":"11","author":"Cutigi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13059-022-02607-z","article-title":"Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource","volume":"23","author":"Dressler","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"174","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1158\/1078-0432.CCR-14-3163","article-title":"Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM\/CaMKK-Mediated Phosphorylation of Akt","volume":"21","author":"Wang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.02.003_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188961","article-title":"RNA m(6)A modification in prostate cancer: A new weapon for its diagnosis and therapy","volume":"1878","author":"Han","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.24976\/Discov.Med.202436180.5","article-title":"ALKBH5 Suppresses Autophagy in Prostate Cancer Cells via Inhibiting m6A-Modification of TSPAN1 mRNA","volume":"36","author":"Zhao","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymthe.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41388-020-1272-x","article-title":"Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis","volume":"39","author":"Goto","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/1873-3468.14598","article-title":"MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3","volume":"597","author":"Asai","year":"2023","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-025-02234-9","article-title":"Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41467-025-56494-6","article-title":"VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107915","article-title":"Precision targeting of androgen receptor-ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies","volume":"219","author":"Lv","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2026.02.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.147999","article-title":"ALKBH5: a double-edged sword in cancer ferroptosis regulation: A review","volume":"330","author":"Huang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102971","article-title":"Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma","volume":"69","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","article-title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140523","article-title":"Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: A review","volume":"302","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217503","article-title":"The YTHDF3-DT\/miR-301a-3p\/INHBA axis attenuates autophagy-dependent ferroptosis in lung adenocarcinoma","volume":"613","author":"Peng","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2022.05.019","article-title":"Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial","volume":"82","author":"Crabb","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.annonc.2020.01.074","article-title":"A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer","volume":"31","author":"Kolinsky","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.20.01576","article-title":"Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)","volume":"39","author":"Crabb","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.02.003_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114103","article-title":"Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial","volume":"205","author":"Rescigno","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:35:36Z","timestamp":1781829336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626000882"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.003","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALKBH5 orchestrates ferroptosis-driven tumor suppression: An LLM-powered discovery in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}